(Total Views: 129)
Posted On: 12/07/2022 9:55:46 AM
Post# of 47159

$RXDX News Article - Prometheus Biosciences Announces Positive Results for PRA023 in Both ARTEMIS-UC Phase 2 and APOLLO-CD Phase 2a Studies Enabling Pathway to Both First-in-Class and Best-in-Class Anti-TL1A mAb https://marketwirenews.com/news-releases/prom...83974.html


My Twitter: WhyteStocks